Portfolio Rationales: February 2026 (Copy) 19 Mar Written by Fedor Kolchin Please see our monthly reporting for FebruaryPortfolio Rationales - February 2026 Fedor Kolchin Previous Previous Portfolio Rationales - March 2026 (Copy) Next Next Top Picks: Vaxcyte (PCVX) (Copy)
Portfolio Rationales: February 2026 (Copy) 19 Mar Written by Fedor Kolchin Please see our monthly reporting for FebruaryPortfolio Rationales - February 2026 Fedor Kolchin
